Chondrosarcomas Recruiting Phase 2 Trials for Anlotinib (DB11885)
Also known as: Chondrosarcoma / Chondroma sarcomatosum / Chondrosarcoma NOS / [M]Chondrosarcoma NOS
| Indication | Status | Phase |
|---|---|---|
| DBCOND0036125 (Chondrosarcomas) | Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05193188 | A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma | Treatment |